These titles certainly did more than shake the industry when they premiered. However, they've been unable to maintain their ...

Mark Sammut grew up on the PlayStation 1 and has been playing games ever since, although he is no longer limited to just Sony consoles. Be it JRPGs, shooters, platformers, or hack and slash games, ...

These are the 15 highest-grossing animated feature films of all time. Franchise hits like "Toy Story" and "Minions" and musicals like "Frozen" and "The Lion King" dominated the list. The list is ...

2025 came to a close with animation as globally dominant as ever. Ne Zha 2 topped the worldwide box office with $2.21 billion, followed by Walt Disney Animation’s Zootopia 2, which came out hot in ...

2025 has been one of the strongest years for anime in ages, building on what is clearly a new Golden Age in the Japanese animation industry. With widening viewership, more access to anime on streaming ...

We’re wrapping up the year by naming some of the best of the best anime to come out this year. Japanese animation has quickly become the genre to prioritize for studios and streamers, with American ...

Yes, “KPop Demon Hunters” makes the list. But that was just one of the standouts in a great year. By Maya Phillips My list of favorite animation this year includes time-traveling rainbow people, ...

Animation has always enjoyed a devoted following, but 2025’s releases revealed that its audience is bigger and broader than most of us thought. In a tough year for most live-action releases, one of ...

In many ways, 2025 was a banner year for anime: There were box-office smashes, such as Demon Slayer: Infinity Castle grossing close to $800 million worldwide, alongside a less quantifiable shift in ...

Daiichi Sankyo and Merck & Co.’s phase 3 program for their investigational antibody-drug conjugate has been hit with a hold after an unexpected number of deaths were reported in the global trial. “Due ...

The FDA has approved trastuzumab deruxtecan (T-DXd; Enhertu, Daiichi Sankyo/AstraZeneca) in combination with pertuzumab for the first-line treatment of unresectable or metastatic HER2-positive breast ...